SYNTHESIS AND PHARMACOLOGICAL CHARACTERIZATION OF 1-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE, 4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLINE, AND 1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE AS DOPAMINE RECEPTOR LIGANDS

被引：42
作者：
CHARIFSON, PS
WYRICK, SD
HOFFMAN, AJ
SIMMONS, RMA
BOWEN, JP
MCDOUGALD, DL
MAILMAN, RB
机构：
[1] UNIV N CAROLINA,SCH PHARM,DIV MED CHEM & NAT PROD,CHAPEL HILL,NC 27599
[2] UNIV N CAROLINA,SCH MED,DEPT PSYCHIAT,BIOL SCI RES CTR,CHAPEL HILL,NC 27599
[3] UNIV N CAROLINA,SCH MED,DEPT PHARMACOL,CHAPEL HILL,NC 27599
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 1988年 / 31卷 / 10期
关键词：
D O I：
10.1021/jm00118a012
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：1941 / 1946
页数：6
相关论文
共 35 条
[1]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[2]  
CALNE DB, 1980, TRENDS PHARM SCI, V3, P412
[3]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[4]   PHARMACOLOGICAL EFFECTS OF A SPECIFIC DOPAMINE D-1 ANTAGONIST SCH-23390 IN COMPARISON WITH NEUROLEPTICS [J].
CHRISTENSEN, AV ;
ARNT, J ;
HYTTEL, J ;
LARSEN, JJ ;
SVENDSEN, O .
LIFE SCIENCES, 1984, 34 (16) :1529-1540
[5]  
Clarke H. T., 1933, J AM CHEM SOC, V55, P4571, DOI 10.1021/ja01338a041
[6]  
CLEMENTCORMIER YC, 1979, BIOCH PHARM, V23, P3123
[7]   OCCURRENCE OF A NEW CLASS OF TETRAHYDROISOQUINOLINE ALKALOIDS IN L-DOPA-TREATED PARKINSONIAN PATIENTS [J].
COSCIA, CJ ;
BURKE, W ;
JAMROZ, G ;
LASALA, JM ;
MCFARLANE, J ;
MITCHELL, J ;
OTOOLE, MM ;
WILSON, ML .
NATURE, 1977, 269 (5629) :617-619
[8]  
COSTENTIN J, 1983, CNS RECEPTORS MOL PH, P289
[9]   DOPAMINE-RECEPTORS IN THE CENTRAL NERVOUS-SYSTEM [J].
CREESE, I ;
MORROW, AL ;
LEFF, SE ;
SIBLEY, DR ;
HAMBLIN, MW .
INTERNATIONAL REVIEW OF NEUROBIOLOGY, 1982, 23 :255-301
[10]   THE CLASSIFICATION OF DOPAMINE-RECEPTORS - RELATIONSHIP TO RADIOLIGAND BINDING [J].
CREESE, I ;
SIBLEY, DR ;
HAMBLIN, MW ;
LEFF, SE .
ANNUAL REVIEW OF NEUROSCIENCE, 1983, 6 :43-71
1234